A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease Continuum.

Alzheimer’s disease cognition cognitive reserve functional MRI intrinsic network connectivity resting-state functional connectivity

Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2023
Historique:
medline: 12 4 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

Cognitive reserve (CR) explains inter-individual differences in the impact of the neurodegenerative burden on cognitive functioning. A residual model was proposed to estimate CR more accurately than previous measures. However, associations between residual CR markers (CRM) and functional connectivity (FC) remain unexplored. To explore the associations between the CRM and intrinsic network connectivity (INC) in resting-state networks along the neuropathological-continuum of Alzheimer's disease (ADN). Three hundred eighteen participants from the DELCODE cohort were stratified using cerebrospinal fluid biomarkers according to the A(myloid-β)/T(au)/N(eurodegeneration) classification. CRM was calculated utilizing residuals obtained from a multilinear regression model predicting cognition from markers of disease burden. Using an independent component analysis in resting-state fMRI data, we measured INC of resting-state networks, i.e., default mode network (DMN), frontoparietal network (FPN), salience network (SAL), and dorsal attention network. The associations of INC with a composite memory score and CRM and the associations of CRM with the seed-to-voxel functional connectivity of memory-related were tested in general linear models. CRM was positively associated with INC in the DMN in the entire cohort. The A+T+N+ group revealed an anti-correlation between the SAL and the DMN. Furthermore, CRM was positively associated with anti-correlation between memory-related regions in FPN and DMN in ADN and A+T/N+. Our results provide evidence that INC is associated with CRM in ADN defined as participants with amyloid pathology with or without cognitive symptoms, suggesting that the neural correlates of CR are mirrored in network FC in resting-state.

Sections du résumé

BACKGROUND
Cognitive reserve (CR) explains inter-individual differences in the impact of the neurodegenerative burden on cognitive functioning. A residual model was proposed to estimate CR more accurately than previous measures. However, associations between residual CR markers (CRM) and functional connectivity (FC) remain unexplored.
OBJECTIVE
To explore the associations between the CRM and intrinsic network connectivity (INC) in resting-state networks along the neuropathological-continuum of Alzheimer's disease (ADN).
METHODS
Three hundred eighteen participants from the DELCODE cohort were stratified using cerebrospinal fluid biomarkers according to the A(myloid-β)/T(au)/N(eurodegeneration) classification. CRM was calculated utilizing residuals obtained from a multilinear regression model predicting cognition from markers of disease burden. Using an independent component analysis in resting-state fMRI data, we measured INC of resting-state networks, i.e., default mode network (DMN), frontoparietal network (FPN), salience network (SAL), and dorsal attention network. The associations of INC with a composite memory score and CRM and the associations of CRM with the seed-to-voxel functional connectivity of memory-related were tested in general linear models.
RESULTS
CRM was positively associated with INC in the DMN in the entire cohort. The A+T+N+ group revealed an anti-correlation between the SAL and the DMN. Furthermore, CRM was positively associated with anti-correlation between memory-related regions in FPN and DMN in ADN and A+T/N+.
CONCLUSION
Our results provide evidence that INC is associated with CRM in ADN defined as participants with amyloid pathology with or without cognitive symptoms, suggesting that the neural correlates of CR are mirrored in network FC in resting-state.

Identifiants

pubmed: 36806502
pii: JAD220464
doi: 10.3233/JAD-220464
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

925-940

Auteurs

Ersin Ersoezlue (E)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.
Department of Gerontopsychiatry and Developmental Disorders, kbo-Isar-Amper-Klinikum Haar, University Teaching Hospital of LMU Munich, Germany.

Robert Perneczky (R)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE) Munich, Germany.
Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College, London, UK.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Sheffield Institute for Translational Neurology (SITraN), University of Sheffield, Sheffield, UK.

Maia Tato (M)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Julia Utecht (J)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Carolin Kurz (C)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Jan Häckert (J)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Selim Guersel (S)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Lena Burow (L)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Gabriele Koller (G)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Sophia Stoecklein (S)

Department of Radiology, University Hospital, LMU Munich, Germany.

Daniel Keeser (D)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Boris Papazov (B)

Department of Radiology, University Hospital, LMU Munich, Germany.

Marie Totzke (M)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.

Tommaso Ballarini (T)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.

Frederic Brosseron (F)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.

Katharina Buerger (K)

German Center for Neurodegenerative Diseases (DZNE Munich), Munich, Germany.
Institute for Stroke and Dementia Research (ISD), University Hospital LMU Munich, Germany.

Peter Dechent (P)

MR-Research in Neurosciences Department of Cognitive Neurology, Georg-August-University Goettingen, Germany.

Laura Dobisch (L)

German Center for Neurodegenerative Diseases (DZNE) Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University Magdeburg, Germany.

Michael Ewers (M)

German Center for Neurodegenerative Diseases (DZNE Munich), Munich, Germany.
Institute for Stroke and Dementia Research (ISD), University Hospital LMU Munich, Germany.

Klaus Fliessbach (K)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Medical Center of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Germany.

Wenzel Glanz (W)

German Center for Neurodegenerative Diseases (DZNE) Magdeburg, Germany.

John Dylan Haynes (JD)

Bernstein Center for Computational Neuroscience Charité - Universitätsmedizin Berlin, Germany.

Michael T Heneka (MT)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Medical Center of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Germany.

Daniel Janowitz (D)

Institute for Stroke and Dementia Research (ISD), University Hospital LMU Munich, Germany.

Ingo Kilimann (I)

German Center for Neurodegenerative Diseases (DZNE) Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Luca Kleineidam (L)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.

Christoph Laske (C)

German Center for Neurodegenerative Diseases (DZNE) Tübingen, Germany.
Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Germany.

Franziska Maier (F)

Department of Psychiatry, Medical Faculty of University of Cologne, Germany.

Matthias H Munk (MH)

German Center for Neurodegenerative Diseases (DZNE) Tübingen, Germany.
Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Germany.

Oliver Peters (O)

Department of Psychiatry, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE) Berlin, Germany.

Josef Priller (J)

Department of Psychiatry and Psychotherapy, Charité Berlin, Germany.
Department of Psychiatry and Psychotherapy, School of Medicine Technical University of Munich, Germany.
University of Edinburgh and UK DRI Edinburgh, UK.

Alfredo Ramirez (A)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Medical Center of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Germany.
Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, Germany.
Department of Psychiatry & Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, TX, USA.

Sandra Roeske (S)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.

Nina Roy (N)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.

Klaus Scheffler (K)

Department for Biomedical Magnetic Resonance, University of Tübingen, Germany.

Anja Schneider (A)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Medical Center of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Germany.

Björn H Schott (BH)

German Center for Neurodegenerative Diseases (DZNE) Goettingen, Germany.
Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Germany.
Leibniz Institute for Neurobiology, Magdeburg, Germany.

Annika Spottke (A)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Department of Neurology, University of Bonn, Germany.

Eike J Spruth (EJ)

German Center for Neurodegenerative Diseases (DZNE) Berlin, Germany.
Department of Psychiatry and Psychotherapy, Charité Berlin, Germany.

Stefan Teipel (S)

German Center for Neurodegenerative Diseases (DZNE) Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Chantal Unterfeld (C)

Department of Psychiatry, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Germany.

Michael Wagner (M)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Medical Center of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Germany.

Xiao Wang (X)

Department of Psychiatry, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Germany.

Jens Wiltfang (J)

German Center for Neurodegenerative Diseases (DZNE) Goettingen, Germany.
Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Germany.
Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Portugal.

Steffen Wolfsgruber (S)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Medical Center of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Germany.

Renat Yakupov (R)

German Center for Neurodegenerative Diseases (DZNE) Magdeburg, Germany.

Emrah Duezel (E)

German Center for Neurodegenerative Diseases (DZNE) Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University Magdeburg, Germany.

Frank Jessen (F)

German Center for Neurodegenerative Diseases (DZNE) Bonn, Germany.
Department of Psychiatry, Medical Faculty of University of Cologne, Germany.
Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) University of Cologne, Germany.

Boris-Stephan Rauchmann (BS)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE) Munich, Germany.
Sheffield Institute for Translational Neurology (SITraN), University of Sheffield, Sheffield, UK.
Department of Neuroradiology, University Hospital, LMU Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH